Physician profile
Brian A Moogerfeld
NPI 1235287004
$758.75
in general payments reported to CMS, 2019-2025
20 companies · $71.22 in 2025
The $71.22 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $55.51 · 2021: $193 · 2022: $84.17 · 2023: $144 · 2024: $211 · 2025: $71.22.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $427.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $426.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $127.55 | 2021-2025 | Repatha, Otezla, Repatha |
| Novartis Pharmaceuticals Corporation | $64.31 | 2022-2025 | |
| Abbott Laboratories | $59.94 | 2021-2023 | Freestyle Libre |
| Novo Nordisk INC | $55.45 | 2023-2025 | Wegovy |
| Glaxosmithkline, LLC. | $48.44 | 2024 | Shingrix, Arexvy |
| Abbvie INC. | $46.59 | 2024 | |
| Sunovion Pharmaceuticals INC. | $45.98 | 2021 | |
| Lilly USA, LLC | $44.16 | 2023-2024 | Jardiance, Mounjaro |
| Boehringer Ingelheim Pharmaceuticals, INC. | $42.23 | 2019 | |
| Pfizer INC. | $31.43 | 2021-2023 | |
| Kowa Pharmaceuticals America, INC. | $27.38 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $26.57 | 2019-2022 | |
| Janssen Pharmaceuticals, INC | $26.00 | 2021 | |
| Xeris Pharmaceuticals, INC. | $23.20 | 2021 | |
| Nevro Corp. | $18.88 | 2023 | Senza |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ibsa Pharma INC. | $15.60 | 2023 | Tirosint, Licart |
| E.R. Squibb & Sons, L.L.C. | $14.61 | 2024 | Eliquis |
| Esperion Therapeutics, INC. | $13.80 | 2024 | Nexletol |
| Baxter Healthcare | $13.56 | 2023 | Hillrom - Carnation Ambulatory Monitor |
| Bayer Healthcare Pharmaceuticals INC. | $13.07 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Moogerfeld listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.